Johnson & Johnson (FRA:JNJ)
€ 138.92 -0.18 (-0.13%) Market Cap: 334.68 Bil Enterprise Value: 341.56 Bil PE Ratio: 9.88 PB Ratio: 5.15 GF Score: 83/100

Johnson & Johnson Citi 'Of Hearts and Minds' Conference Call Series Transcript

Jul 27, 2020 / 07:00PM GMT
Release Date Price: €126.04 (-0.60%)
Operator

Good day. And welcome to the Citi-hosted 'Of Hearts and Minds Johnson & Johnson Conference Call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Joanne Wuensch, Managing Director of Citi Research. Please go ahead, ma'am.

Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

Everybody, welcome to this hot Monday afternoon. Thank you for joining us as we kick off the next Citi Research health care series, Of Hearts and Minds.

Today, we're thrilled to have from Johnson & Johnson Ashley McEvoy, the Executive Vice President and Worldwide Chairman of the Medical Device business. Just before we get started, if there is anybody from the press which is on this call, please disconnect as this is a call that is not for the press at this time.

Okay. Moving on. So Ashley, in her role, leads the surgery, orthopedics, interventional solutions and eye health care businesses at J&J, which generated approximately $26 billion in revenue in 2019. Just to sort of ground this franchise within the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot